Clinical Trials Browser

Phase 2 × SHR-1701 × Dermatologic × Clear all

NCT05106023 2023-06-07

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

Phase 2 Unknown

Melanoma